Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol

被引:73
作者
Rusert, P
Fischer, M
Joos, B
Leemann, C
Kuster, H
Flepp, M
Bonhoeffer, S
Günthard, HF
Trkola, A
机构
[1] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Hosp Epidemiol, CH-8091 Zurich, Switzerland
[3] ETH, Inst Ecol, CH-8092 Zurich, Switzerland
关键词
HIV; plasma viremia; infectious titer; virus isolation;
D O I
10.1016/j.virol.2004.05.022
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Methods currently used for HIV-1 viral load measurements are very sensitive, but cannot distinguish between infectious and noninfectious particles. Here we describe the development of a novel, sensitive, and highly reproducible method that allows rapid isolation and quantification of infectious particles from patient plasma. By immobilizing HIV-1 particles inhuman plasma to platelets using polybrene, we observed a 10-to 1000-fold increase in infectivity over infection protocols using free virus particles. Using this method, we evaluated infectivity in plasma from 52 patients at various disease stages. At plasma viral loads of 1000-10000 HIV-1 RNA copies/ml 18%, at 10000-50000 copies/m173%, at 50000-100000 copies/ml 90%, and above 100 000 copies 96% of cultures were positive. We found that infectious titers among patients vary distinctively but are characteristic for a patient over extended time periods. Furthermore, we demonstrate that by evaluating infectious titers in conjunction with total HIV RNA loads, subtle effects of treatment intervention on viremia levels can be detected. The immobilization procedure does not interfere with viral entry and does not restore the infectivity of neutralized virus. Therefore, this assay system can be utilized to investigate the influence of substances that specifically affect virion infectivity such as neutralizing antibodies, soluble CD4, or protease inhibitors. Measuring viral infectivity may thereby function as an additional, useful marker in monitoring disease progression and evaluating efficacy of antivirals in vivo. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:113 / 129
页数:17
相关论文
共 72 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES [J].
ALLAWAY, GP ;
DAVISBRUNO, KL ;
BEAUDRY, GA ;
GARCIA, EB ;
WONG, EL ;
RYDER, AM ;
HASEL, KW ;
GAUDUIN, MC ;
KOUP, RA ;
MCDOUGAL, JS ;
MADDON, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :533-539
[3]   EFFICIENT AND REPRODUCIBLE NEW SEMIMICROMETHOD FOR THE DETECTION AND TITRATION OF HIV IN HUMAN PLASMA [J].
ANDREONI, M ;
SARMATI, L ;
PARISI, SG ;
ERCOLI, L ;
ROCCHI, G .
JOURNAL OF MEDICAL VIROLOGY, 1992, 38 (03) :207-213
[4]   Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral [J].
Andreoni, M ;
Sarmati, L ;
Ercoli, L ;
Nicastri, E ;
Giannini, G ;
Galluzzo, C ;
Pirillo, MF ;
Vella, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (07) :555-561
[5]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027
[6]   Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus [J].
Chertova, E ;
Bess, JW ;
Crise, BJ ;
Sowder, RC ;
Schaden, TM ;
Hilburn, JM ;
Hoxie, JA ;
Benveniste, RE ;
Lifson, JD ;
Henderson, LE ;
Arthur, LO .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5315-5325
[7]   PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells [J].
Christopherson, C ;
Kidane, Y ;
Conway, B ;
Krowka, J ;
Sheppard, H ;
Kwok, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :630-634
[8]   CELL-FREE PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TITER ASSESSED BY CULTURE AND IMMUNOCAPTURE-REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION [J].
COOMBS, RW ;
HENRARD, DR ;
MEHAFFEY, WF ;
GIBSON, J ;
EGGERT, E ;
QUINN, TC ;
PHILLIPS, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) :1980-1986
[9]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[10]   Is human immunodeficiency virus RNA load composed of neutralized immune complexes? [J].
Dianzani, F ;
Antonelli, G ;
Riva, E ;
Turriziani, O ;
Antonelli, L ;
Tyring, S ;
Carrasco, DA ;
Lee, H ;
Nguyen, D ;
Pan, JZ ;
Poast, J ;
Cloyd, M ;
Baron, S .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (08) :1051-1054